Effectiveness and safety of weight-loss drugs based on glucagon-like peptide 1 in adults with overweight or obesity without diabetes

A comparison of glucagon-like peptide 1 (GLP-1) based drug treatments for weight loss in adults with overweight or obesity without diabetes was conducted.

• The efficacy of GLP-1 based treatments for weight loss may vary among individuals.
• Safety profiles of these treatments are essential to evaluate alongside their effectiveness.
• The study focuses on adults who are overweight or obese but do not have diabetes.

Simplified